NGeneBio Co., Ltd. (KOSDAQ:354200)
1,622.00
-98.00 (-5.70%)
At close: Sep 3, 2026
NGeneBio Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3,000 | 1,943 | 4,430 | 19,275 | 24,897 | 16,296 |
Short-Term Investments | 1,054 | 707.4 | 58.42 | 129.05 | 10,021 | 8,011 |
Trading Asset Securities | 2,492 | 3,025 | 3,008 | 3,023 | - | - |
Cash & Short-Term Investments | 6,546 | 5,675 | 7,496 | 22,427 | 34,918 | 24,307 |
Cash Growth | -45.98% | -24.30% | -66.57% | -35.77% | 43.66% | - |
Accounts Receivable | 12,855 | 13,847 | 699.76 | 788.95 | 1,125 | 1,574 |
Other Receivables | 143.81 | 72.98 | 62.06 | 210.77 | 51.09 | 58.06 |
Receivables | 13,507 | 14,428 | 761.82 | 999.72 | 1,176 | 1,632 |
Inventory | 1,662 | 1,423 | 2,074 | 1,695 | 2,968 | 1,219 |
Prepaid Expenses | 138.91 | 366.84 | 120.57 | 121.5 | 141.72 | 79.67 |
Other Current Assets | 854.55 | 2,483 | 1,220 | 1,779 | 3,868 | 136.73 |
Total Current Assets | 22,709 | 24,377 | 11,672 | 27,021 | 43,072 | 27,374 |
Property, Plant & Equipment | 6,718 | 6,429 | 12,172 | 9,343 | 8,684 | 8,092 |
Long-Term Investments | 1,982 | 1,905 | 1,057 | 2,837 | 1,378 | 5,451 |
Goodwill | 3,221 | 2,983 | 5,388 | 416.32 | 416.32 | 416.32 |
Other Intangible Assets | 1,760 | 1,989 | 2,427 | 1,456 | 1,224 | 1,247 |
Other Long-Term Assets | 34,234 | 34,655 | 233.05 | 1,208 | 1,389 | 1,287 |
Total Assets | 70,623 | 72,338 | 32,950 | 42,282 | 56,164 | 43,867 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 5,200 | 5,140 | 376.67 | 162.75 | 69.18 | 172.85 |
Accrued Expenses | 309.55 | 557.94 | 476.88 | 253.59 | 235.99 | 188.37 |
Short-Term Debt | 32,489 | 32,777 | 6,750 | 11,056 | 10,786 | 6,100 |
Current Portion of Long-Term Debt | 3,512 | - | - | - | - | 362 |
Current Portion of Leases | 308.26 | 318.52 | 1,028 | 241.11 | 295.95 | 161.89 |
Current Unearned Revenue | 12.97 | 0.04 | - | 0 | 20.17 | 18.33 |
Other Current Liabilities | 8,897 | 9,213 | 3,893 | 12,103 | 17,594 | 1,051 |
Total Current Liabilities | 50,729 | 48,006 | 12,525 | 23,816 | 29,001 | 8,055 |
Long-Term Debt | - | - | - | - | - | 500 |
Long-Term Leases | 77.8 | 153.45 | 1,242 | 146.88 | 374.62 | 82.69 |
Pension & Post-Retirement Benefits | 1,042 | 1,088 | 1,465 | 1,935 | 1,297 | 1,188 |
Other Long-Term Liabilities | 87.65 | 497.77 | 10.19 | 150.52 | 165.38 | 43.69 |
Total Liabilities | 51,937 | 49,745 | 15,241 | 26,048 | 30,837 | 9,869 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 8,937 | 25,038 | 19,819 | 12,889 | 12,526 | 12,431 |
Additional Paid-In Capital | 71,252 | 69,035 | 60,909 | 55,102 | 52,570 | 51,982 |
Retained Earnings | -61,812 | -71,661 | -66,297 | -53,941 | -40,886 | -31,381 |
Comprehensive Income & Other | 780.43 | 554.09 | 2,547 | 2,244 | 1,086 | 965.73 |
Total Common Equity | 19,145 | 22,966 | 16,977 | 16,295 | 25,297 | 33,998 |
Minority Interest | -458.39 | -373.77 | 731.71 | -60.68 | 30.24 | - |
Shareholders' Equity | 18,686 | 22,592 | 17,709 | 16,234 | 25,327 | 33,998 |
Total Liabilities & Equity | 70,623 | 72,338 | 32,950 | 42,282 | 56,164 | 43,867 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 36,387 | 33,249 | 9,019 | 11,444 | 11,456 | 7,207 |
Net Cash (Debt) | -29,842 | -27,574 | -1,523 | 10,983 | 23,462 | 17,100 |
Net Cash Growth | - | - | - | -53.19% | 37.20% | - |
Net Cash Per Share | -3477.48 | -3678.51 | -322.18 | 2597.56 | 5640.72 | 4147.91 |
Filing Date Shares Outstanding | 8.94 | 8.35 | 6.61 | 4.3 | 4.18 | 4.14 |
Total Common Shares Outstanding | 8.94 | 8.35 | 6.61 | 4.3 | 4.18 | 4.14 |
Working Capital | -28,021 | -23,630 | -852.15 | 3,205 | 14,072 | 19,319 |
Book Value Per Share | 2141.41 | 2751.75 | 2569.87 | 3792.66 | 6058.74 | 8204.81 |
Tangible Book Value | 14,164 | 17,994 | 9,162 | 14,422 | 23,656 | 32,334 |
Tangible Book Value Per Share | 1584.29 | 2156.02 | 1386.83 | 3356.84 | 5665.84 | 7803.33 |
Land | 1,929 | 1,929 | 2,696 | 2,696 | 2,584 | 2,584 |
Buildings | 2,893 | 2,893 | 4,044 | 4,044 | 3,040 | 3,040 |
Machinery | 6,663 | 6,890 | 8,422 | 4,962 | 4,569 | 3,699 |
Construction In Progress | 367.04 | - | - | - | 9.23 | - |